Quince Therapeutics, Inc.
- QNCX
- NASDAQ
- Biotechnology
- Bone-Targeting Drug Delivery
- Rare Disease Therapeutics
$31.73
Today +8.07%Quote Oct 9, 2026, 08:00 PM UTC
+9.64%over the last month
Max drawdown −14.8%From 1-month high 0.0%3 months +68.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$32.3M
Quote Oct 9
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$70.00
+120.6% from here
Floor
$31.58
0.5% below price
Where the price sits
5 analysts
Analyst range, low to high
$68.00$72.00
- Price $31.73
- Resistance $31.79
- Consensus $70.00
The price is just above its floor and right under resistance. Analysts' average target sits about 121% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about QNCXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
38